European Union · Question · QUESTION_WRITTEN
E-9-2021-000207
Conditions of access for low- and middle-income countries to the COVID-19 vaccine
Introduced
14 January 2021
Last action
30 March 2021 · Answer
Status
answered
Sponsors
Javi LÓPEZ
Subjects
Discovery layer
Source updated
30 March 2021
Records
Official question E-9-2021-000207 from European Union at European Parliament. Dated 14 January 2021. Status: answered.
Timeline
14 January 2021
Written question
Conditions of access for low- and middle-income countries to the COVID-19 vaccine
Source: QUESTION_WRITTEN
30 March 2021
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Conditions for access to the COVID-19 vaccine for low- and middle-income countries
Conditions for access to the COVID-19 vaccine for low- and middle-income countries
QUESTION_WRITTEN · EN · 27 January 2021
Conditions for access to the COVID-19 vaccine for low- and middle-income countries
QUESTION_WRITTEN · EN · 27 January 2021
Conditions for access to the COVID-19 vaccine for low- and middle-income countries
QUESTION_WRITTEN · EN · 27 January 2021
Answer
QUESTION_WRITTEN_ANSWER · 30 March 2021
Condiciones de acceso de países de renta media y baja a la vacuna contra la COVID-19
QUESTION_WRITTEN · ES · 27 January 2021
Condiciones de acceso de países de renta media y baja a la vacuna contra la COVID-19
QUESTION_WRITTEN · ES · 27 January 2021
Condiciones de acceso de países de renta media y baja a la vacuna contra la COVID-19
QUESTION_WRITTEN · ES · 27 January 2021
Sponsors
- Javi LÓPEZ · AUTHOR
- · EU_COMMISSION · ADDRESSEE
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-9-2021-000207_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-9-2021-000207
- eu · E-9-2021-000207 · source updated 30 March 2021